Alanine racemase mutants of Mycobacterium tuberculosis require D-alanine for growth and are defective for survival in macrophages and mice

Microbiology

Volumn 158, Issue 2, 2012, Pages 319-327

  Awasthy, Disha ^a   Bharath, Sowmya ^a   Subbulakshmi, Venkita ^a   Sharma, Umender ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE RACEMASE; CYCLOSERINE; DEXTRO ALANINE;

ANIMAL CELL; ARTICLE; BACTERIAL CELL; BACTERIAL CLEARANCE; BACTERIAL COUNT; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIAL VIABILITY; BACTERIUM MUTANT; CELL DEATH; CULTURE MEDIUM; GENE INACTIVATION; GENE SILENCING; LUNG; MACROPHAGE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN TARGETING; SPLEEN;

ALANINE; ALANINE RACEMASE; ANIMALS; BACTERIAL PROTEINS; CELLS, CULTURED; HUMANS; MACROPHAGES; MICE; MICE, INBRED BALB C; MICROBIAL VIABILITY; MUTATION; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

BACTERIA (MICROORGANISMS); LISTERIA MONOCYTOGENES; MUS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS;

EID: 84856690515     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.054064-0     Document Type: Article

References (30)

1. Anthony, K. G., Strych, U., Yeung, K. R., Shoen, C. S., Perez, O., Krause, K. L., Cynamon, M. H., Aristoff, P. A. & Koski, R. A. (2011). New classes of alanine racemase inhibitors identified by highthroughput screening show antimicrobial activity against Mycobacterium tuberculosis. PLoS ONE 6, e20374.
2. Awasthy, D., Gaonkar, S., Shandil, R. K., Yadav, R., Bharath, S., Marcel, N., Subbulakshmi, V. & Sharma, U. (2009). Inactivation of the ilvB1 gene in Mycobacterium tuberculosis leads to branched-chain amino acid auxotrophy and attenuation of virulence in mice. Microbiology 155, 2978-2987
3. Bruning, J. B., Murillo, A. C., Chacon, O., Barletta, R. G. & Sacchettini, J. C. (2011). Structure of the Mycobacterium tuberculosis D-alanine: Dalanine ligase, a target of the antituberculosis drug D-cycloserine. Antimicrob Agents Chemother 55, 291-301
4. Cáceres, N. E., Harris, N. B., Wellehan, J. F., Feng, Z., Kapur, V. & Barletta, R. G. (1997). Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis. J Bacteriol 179, 5046-5055
5. Chacon, O., Feng, Z., Harris, N. B., Cáceres, N. E., Adams, L. G. & Barletta, R. G. (2002). Mycobacterium smegmatis D-alanine racemase mutants are not dependent on D-alanine for growth. Antimicrob Agents Chemother 46, 47-54
6. Chacon, O., Bermudez, L. E., Zinniel, D. K., Chahal, H. K., Fenton, R. J., Feng, Z., Hanford, K., Adams, L. G. & Barletta, R. G. (2009). Impairment of D-alanine biosynthesis in Mycobacterium smegmatis determines decreased intracellular survival in human macrophages. Microbiology 155, 1440-1450
7. Chan, E. D. & Iseman, M. D. (2008). Multidrug-resistant and extensively drug-resistant tuberculosis: a review. Curr Opin Infect Dis 21, 587-595
8. Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S. & other authors (1998). Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537-544
9. Feng, Z. & Barletta, R. G. (2003). Roles of Mycobacterium smegmatis D-alanine: D-alanine ligase and D-alanine racemase in the mechanisms of action of and resistance to the peptidoglycan inhibitor Dcycloserine. Antimicrob Agents Chemother 47, 283-291
10. Franzblau, S. G., Witzig, R. S., McLaughlin, J. C., Torres, P., Madico, G., Hernandez, A., Degnan, M. T., Cook, M. B., Quenzer, V. K. & other authors (1998). Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol 36, 362-366
11. Ginsberg, A. M. (2010). Tuberculosis drug development: progress, challenges, and the road ahead. Tuberculosis (Edinb) 90, 162-167
12. Halouska, S., Chacon, O., Fenton, R. J., Zinniel, D. K., Barletta, R. G. & Powers, R. (2007). Use of NMR metabolomics to analyze the targets of D-cycloserine in mycobacteria: role of D-alanine racemase. J Proteome Res 6, 4608-4614
13. Heaton, M. P., Johnston, R. B. & Thompson, T. L. (1988). Controlled lysis of bacterial cells utilizing mutants with defective synthesis of Dalanine. Can J Microbiol 34, 256-261
14. Hols, P., Defrenne, C., Ferain, T., Derzelle, S., Delplace, B. & Delcour, J. (1997). The alanine racemase gene is essential for growth of Lactobacillus plantarum. J Bacteriol 179, 3804-3807
15. Kaufmann, S. H., Hussey, G. & Lambert, P. H. (2010). New vaccines for tuberculosis. Lancet 375, 2110-2119
16. Kurokawa, K., Hamamoto, H., Matsuo, M., Nishida, S., Yamane, N., Lee, B. L., Murakami, K., Maki, H. & Sekimizu, K. (2009). Evaluation of target specificity of antibacterial agents using Staphylococcus aureus ddlA mutants and D-cycloserine in a silkworm infection model. Antimicrob Agents Chemother 53, 4025-4027
17. LeMagueres, P., Im, H., Ebalunode, J., Strych, U., Benedik, M. J., Briggs, J. M., Kohn, H. & Krause, K. L. (2005). The 1.9 A ° crystal structure of alanine racemase from Mycobacterium tuberculosis contains a conserved entryway into the active site. Biochemistry 44, 1471-1481
18. Milligan, D. L., Tran, S. L., Strych, U., Cook, G. M. & Krause, K. L. (2007). The alanine racemase of Mycobacterium smegmatis is essential for growth in the absence of D-alanine. J Bacteriol 189, 8381-8386
19. Mitchison, D. A. (2000). Role of individual drugs in the chemotherapy of tuberculosis. Int J Tuberc Lung Dis 4, 796-806
20. Palumbo, E., Favier, C. F., Deghorain, M., Cocconcelli, P. S., Grangette, C., Mercenier, A., Vaughan, E. E. & Hols, P. (2004). Knockout of the alanine racemase gene in Lactobacillus plantarum results in septation defects and cell wall perforation. FEMS Microbiol Lett 233, 131-138
21. Parish, T. & Stoker, N. G. (2000). Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement. Microbiology 146, 1969-1975
22. Steen, A., Palumbo, E., Deghorain, M., Cocconcelli, P. S., Delcour, J., Kuipers, O. P., Kok, J., Buist, G. & Hols, P. (2005). Autolysis of Lactococcus lactis is increased upon D-alanine depletion of peptidoglycan and lipoteichoic acids. J Bacteriol 187, 114-124
23. Strych, U., Penland, R. L., Jimenez, M., Krause, K. L. & Benedik, M. J. (2001). Characterization of the alanine racemases from two mycobacteria. FEMS Microbiol Lett 196, 93-98
24. Thompson, R. J., Bouwer, H. G., Portnoy, D. A. & Frankel, F. R. (1998). Pathogenicity and immunogenicity of a Listeria monocytogenes strain that requires D-alanine for growth. Infect Immun 66, 3552-3561
25. Vilchèze, C., Morbidoni, H. R., Weisbrod, T. R., Iwamoto, H., Kuo, M., Sacchettini, J. C. & Jacobs, W. R., Jr (2000). Inactivation of the inhAencoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis. J Bacteriol 182, 4059-4067
26. Wasserman, S. A., Walsh, C. T. & Botstein, D. (1983). Two alanine racemase genes in Salmonella typhimurium that differ in structure and function. J Bacteriol 153, 1439-1450
27. Wei, J. R., Krishnamoorthy, V., Murphy, K., Kim, J. H., Schnappinger, D., Alber, T., Sassetti, C. M., Rhee, K. Y. & Rubin, E. J. (2011). Depletion of antibiotic targets has widely varying effects on growth. Proc Natl Acad Sci U S A 108, 4176-4181
28. Wells, C. D., Cegielski, J. P., Nelson, L. J., Laserson, K. F., Holtz, T. H., Finlay, A., Castro, K. G. & Weyer, K. (2007). HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 196 (Suppl. 1), S86-S107.
29. Wijsman, H. J. (1972). The characterization of an alanine racemase mutant of Escherichia coli. Genet Res 20, 269-277
30. Zygmunt, W. A. (1963). Antagonism of D-cycloserine inhibition of mycobacterial growth by D-alanine. J Bacteriol 85, 1217-1220.